Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
Lin
Y
Y
Laboratory for Experimental Transplantation, University of Leuven, Belgium.
Waer
M
M
D000818:Animals; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology* / Q000502:physiology; D007108:Immune Tolerance; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007555:Isoxazoles / Q000627:therapeutic use*; D000077339:Leflunomide; D011090:Polyenes / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains; D020123:Sirolimus; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D011090:Polyenes; D016572:Cyclosporine; D000077339:Leflunomide; D020123:Sirolimus